Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Association of Annexin A5 Resistance with Silent Infarct in Sickle Cell Disease

Kerry A. Morrone, MD, Xue Xiaonan, PhD, Suzette O. Oyeku, MD MPH, Jane A. Little, MD, Catherine Driscoll, MD, Jacob Rand, MD, Deepa Manwani, MD

Blood (2014) 124 (21): 1394.

https://doi.org/10.1182/blood.V124.21.1394.1394

Published: 2014

Journal Articles

Analysis Of a Single Institutional Cohort Of 20,593 Patients Tested For Antiphospholipid Antibodies Indicates Significant Prospective Risk For Thrombosis

D. Yitzchak Goldstein, MD, Jacob Rand, MD, Lucia R Wolgast, MD

Blood (2013) 122 (21): 2366.

https://doi.org/10.1182/blood.V122.21.2366.2366

Published: 2013

Journal Articles

A Functional Assay for Annexin A5 Resistance Identifies a Thrombogenic Mechanism In a Subset of Patients with Antiphospholipid Antibodies

Lucia Wolgast, MD, Xiao Xuan Wu, MD, Jessica Niakan, MD, Alan Arslan, MD, Jacob Rand, MD

Blood (2010) 116 (21): 153.

https://doi.org/10.1182/blood.V116.21.153.153

Published: 2010

Journal Articles

Hydroxychloroquine Protects the Annexin A5 Anticoagulant Shield from Disruption by Antiphospholipid Antibodies

Jacob Rand, MD, Xiao-Xuan Wu, MD, Anthony Ashton, PhD

Blood (2008) 112 (11): 404.

https://doi.org/10.1182/blood.V112.11.404.404

Published: 2008

Journal Articles

The Antiphospholipid Syndrome: The Mount Sinai Hematology Perspective.

Maria Teresa De Sancho, MD, Gonzalo Estupinan, Ilene Schulman, NP, Mayra Lema, Jacob Rand, MD

Blood (2005) 106 (11): 2154.

https://doi.org/10.1182/blood.V106.11.2154.2154

Published: 2005

Journal Articles

A Sensitive Enzyme-Linked Assay of ADAMTS13 Antibodies for Diagnosis of TTP.

Mojgan Raoufi, MS, Wenhua Zhou, PhD, Enriqueta Guinto, PhD, Nick Grafos, BS, Safi Ranzurmal, BS, Robert S. Greenfield, PhD, Jacob Rand, MD, Han-Mou Tsai, MD

Blood (2005) 106 (11): 553.

https://doi.org/10.1182/blood.V106.11.553.553

Published: 2005

Journal Articles

Unreliability of Point of Care Devices for INR Monitoring of Oral Anticoagulant Therapy. A Re-Evaluation.

Caryn O. Sands, MD, Vilma Padilla, Khrishan Naraine, Jacob Rand, MD, Amy S. Fox, MD, MS

Blood (2004) 104 (11): 2206.

https://doi.org/10.1182/blood.V104.11.2206.2206

Published: 2004

Journal Articles

A Novel Flow Cytometric Annexin A5 Competition Assay for the Diagnosis of Antiphospholipid Syndrome.

Lisa Senzel, MD PhD, Xiao-Xuan Wu, MD, Jacob Rand, MD.

Blood (2004) 104 (11): 4042.

https://doi.org/10.1182/blood.V104.11.4042.4042

Published: 2004

NARROW

Association of Annexin A5 Resistance with Silent Infarct in Sickle Cell Disease

Analysis Of a Single Institutional Cohort Of 20,593 Patients Tested For Antiphospholipid Antibodies Indicates Significant Prospective Risk For Thrombosis

A Functional Assay for Annexin A5 Resistance Identifies a Thrombogenic Mechanism In a Subset of Patients with Antiphospholipid Antibodies

Hydroxychloroquine Protects the Annexin A5 Anticoagulant Shield from Disruption by Antiphospholipid Antibodies

The Antiphospholipid Syndrome: The Mount Sinai Hematology Perspective.

A Sensitive Enzyme-Linked Assay of ADAMTS13 Antibodies for Diagnosis of TTP.

Unreliability of Point of Care Devices for INR Monitoring of Oral Anticoagulant Therapy. A Re-Evaluation.

A Novel Flow Cytometric Annexin A5 Competition Assay for the Diagnosis of Antiphospholipid Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only